Chris Hourigan
Chris Hourigan

Profile Details

Login Credentials

Contact Name:
Chris Hourigan
Brief Bio:
Chris Hourigan is President, Janssen Japan and a member of the Janssen Asia Pacific Leadership Team.

Before moving into his current role in Japan, Chris was the Managing Director for Janssen Australia & New Zealand (ANZ), where he developed strong business leaders among his team and also played a key role in supporting the local industry as a member of the Medicines Australia Board. Chris also initiated the development of a Johnson & Johnson signature program for disadvantaged indigenous populations in collaboration with the local J&J Board. Before leading Janssen ANZ, Chris was the Managing Director of Janssen Vietnam, where he focused on building a long-term strategy to drive transformational growth for the pharmaceutical business in this high growth AP market. Before this role, Chris was Country Manager for Janssen New Zealand and a board member of the industry association, Medicines New Zealand, and the Janssen Australia New Zealand Leadership Team. During 2008 and 2009, he was the Global Marketing Leader for Psychiatry based in the USA, where he led the development of the antipsychotic long-acting franchise, including Risperdal Consta and Invega Sustenna. Chris joined Johnson and Johnson through Janssen Australia in 2005, as the Marketing Manager for the General Medicine franchise. In 2006, he was appointed Associate Business Unit Director for CNS and also had Asia Pacific regional marketing responsibility for Concerta. In the 13 years before joining J&J, he worked for other pharmaceutical companies.

Chris holds a Masters of Business Administration and a Bachelor of Applied Science.

Contact Information

First Name:
Chris
Last Name:
Hourigan
Position:
President
Organization:
Janssen Japan KK

Other Information

Asia Pacific Meeting Faculty:
2017 AP Mtg Faculty